Objectives : The object of this study was to observe the pharmacological effects of Yookmijihwang-tang-gamibang (Liuweidihuang-tang-jiaweifang, YGB) consisted of 17 types of herbs has been traditionally used in Korean medicine for treating various disorders in clinics, aqueous extracts on the genetically obese and type II diabetic C57BL/6JHamob/ob(ob/ob) mice.
Results : After end of 28 days of continuous treatments, ob/ob control showed increases of adipocyte hypertrophy, vasodilated atrophic glomerulus which were detected with marked hyperplasia of pancreatic islets, insulin and glucagon producing cells. These obese and related type II diabetes induced in ob/ob mice were markedly and significantly inhibited by 28 days of continuous treatment of three dosages of YGB. The YGB 50㎎/㎏ showed similar favorable effects on the diabetes and related diabetic complications as compared with CLA 750㎎/㎏ in ob/ob mice of the present study.
Conclusions : The results obtained in this study suggest that over 25㎎/㎏ of YGB extracts favorably retarded the obese and type II diabetes in genetically obese and type II diabetic ob/ob mice. (Figure 1 ).
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At (Figure 4 ). Figure 3 . Changes on the plasma insulin levels in intact or ob/ob mice Note that significant increases of plasma insulin levels were detected in ob/ob control as compared with intact control. However, these increases of plasma insulin levels were significantly inhibited by treatment of CLA, YGB 25, 50 and 100㎎/㎏ as compared with ob/ob control, respectively Values are expressed as Mean ± SD of five mice YGB: Yookmijihwang-tang-gamibang aqueous extracts CLA: conjugated linoleic acid, reference, 750㎎/㎏ a p<0.01 as compared with intact control by LSD test b p<0.01 as compared with ob/ob control by LSD test Figure 4 . Changes on the pancreatic islet numbers and occupied regions percentage in intact or ob/ob mice Note that significant increases of pancreatic islet numbers and percentages of islet occupied regions were detected in ob/ob control as compared with intact control, results from marked hyperplasia of pancreatic islet itself or component endocrine cells, respectively. However, these hyperplasia and expansion of islets were significantly reduced by treatment of CLA and all three different dosages of YGB as compared with ob/ob control, respectively. 
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